![](/img/cover-not-exists.png)
P502 Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment
Zezos, P., Kabakchiev, B., Weizman, A.V., Nguyen, G.C., Narula, N., Croitoru, K., Steinhart, A.H., Silverberg, M.S.Volume:
11
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx002.626
Date:
February, 2017
File:
PDF, 186 KB
english, 2017